FDA Approved: TIROSINT — Original Application (IBSA Pharma Inc.)

View source ↗

Summary

FDA approved TIROSINT (levothyroxine sodium) from IBSA Pharma Inc. as an Original Application (NDA021924) for replacement therapy in thyroid hormone deficiency …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism
• Goiter
• Hypothyroidism

Drugs mentioned

• TIROSINT (Levothyroxine Sodium)

Snippet

ORIG AP for TIROSINT (LEVOTHYROXINE SODIUM)